Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

150 companies

Ticker	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS ▴
ELUT	Elutia Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$53.38M	n/a	192.9%	n/a	$0.87
TECH	Bio-Techne Corp Manufacturing · Year ended 2026-06-30 · USD	$1.22B	$181.86M	15.0%	8.6%	-0.4%	$1.16
BCRX	BioCryst Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$874.84M	$263.86M	30.2%	n/a	94.1%	$1.21
CHRS	Coherus Oncology, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$168.02M	n/a	275.4%	n/a	$1.43
QGEN	Qiagen N.V. Manufacturing · Year ended 2025-12-31 · USD	$2.09B	$424.88M	20.3%	11.2%	5.7%	$1.94
ENGN	enGene Therapeutics Inc. Manufacturing · Year ended 2025-10-31 · USD	n/a	-$117.30M	n/a	-69.9%	n/a	$2.29
HALO	Halozyme Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.40B	$316.89M	22.7%	649.2%	37.6%	$2.56
ATRA	Atara Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$120.77M	$32.69M	27.1%	n/a	-6.3%	$2.57
NVAX	Novavax Inc Manufacturing · Year ended 2025-12-31 · USD	$1.12B	$440.30M	39.2%	n/a	64.7%	$2.58
EXEL	Exelixis, Inc. Manufacturing · Year ended 2026-01-02 · USD	$2.32B	$782.57M	33.7%	36.2%	7.0%	$2.78
NBIX	Neurocrine Biosciences Inc Manufacturing · Year ended 2025-12-31 · USD	$2.86B	$478.60M	16.7%	14.7%	21.4%	$4.67
GILD	Gilead Sciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$29.44B	$8.51B	28.9%	37.6%	2.4%	$6.78
KRYS	Krystal Biotech, Inc. Manufacturing · Year ended 2025-12-31 · USD	$389.13M	$204.83M	52.6%	16.8%	33.9%	$6.84
BIIB	Biogen Inc. Manufacturing · Year ended 2025-12-31 · USD	$9.89B	$1.29B	13.1%	7.1%	2.2%	$8.79
SLXN	Silexion Therapeutics Corp Manufacturing · Year ended 2025-12-31 · USD	n/a	-$11.91M	n/a	-457.6%	n/a	$8.96
AMGN	Amgen Inc Manufacturing · Year ended 2025-12-31 · USD	$36.75B	$7.71B	21.0%	89.1%	10.0%	$14.23
BCDA	BioCardia, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$8.23M	n/a	-919.3%	-100.0%	n/a
BKHA	Black Hawk Acquisition Corp Manufacturing · Year ended 2025-11-30 · USD	n/a	$1.33M	n/a	n/a	n/a	n/a
CERO	Cero Therapeutics Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$19.92M	n/a	n/a	n/a	n/a
CGEM	Cullinan Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$219.88M	n/a	-53.8%	n/a	n/a
CMPX	Compass Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$66.49M	n/a	-33.8%	-100.0%	n/a
GLUE	Monte Rosa Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$123.67M	-$38.63M	-31.2%	-16.6%	63.5%	n/a
OCGN	Ocugen, Inc. Manufacturing · Year ended 2025-12-31 · USD	$4.41M	-$67.85M	n/m	n/a	8.8%	n/a
PROK	Prokidney Corp. Manufacturing · Year ended 2025-12-31 · USD	$893.0K	-$151.61M	n/m	n/a	n/m	n/a
SCNI	Scinai Immunotherapeutics Ltd. Manufacturing · Year ended 2025-12-31 · USD	$1.31M	-$8.31M	-633.6%	-102.5%	99.2%	n/a

Rows per page: 2550 100